Logo Logo Logo Logo
    • Diabetes and The Foot at Risk “Diabetic Foot”
      • Diabetes and The Foot at Risk “Diabetic Foot”
      • Diabetic Neuropathy and Feet
      • Diabetic Foot Ulcers Wagner Classification
    • About Icorfin
    • Case Study
    • Real Stories
    • es
    • en
    • pt-br

No products in the cart.

Menu
  • es
  • pt-br
My wishlist on IcorfinLogin
  • About Us
  • Medical Area
  • Icorfin® Specifications
  • Contact Us
  • Diabetes and The Foot at Risk “Diabetic Foot”
    • Diabetes and The Foot at Risk “Diabetic Foot”
    • Diabetic Neuropathy and Feet
    • Diabetic Foot Ulcers Wagner Classification
  • About Icorfin
  • Case Study
  • Real Stories
  • es
  • en
  • pt-br
  • Buscar
Home / Francisca Gonzalez

Francisca Gonzalez

June 21, 2017
Display footer
  • WELCOME TO ICORFIN®
    A potent vasodilator that improves circulation and helps decrease foot ulcers granulation time in patients with diabetes, evolution time and treatment costs, and the psychological impact and risk of amputation, after a 12-weeks follow-up. If you wish to contact us please write to: info@icorfin.com
  • Quick Menu
    • Diabetes and The Foot at Risk
    • About Icorfin
    • Case Study
    • Real Stories
  • of your interest
    • About Us
    • Medical Area
    • Icorfin® Specifications
    • Contact Us
  • Subscribe
Copy Right Icorfin® 2016 - Malesil Research and Technology